Characteristics of the Study Cohort According to the Occurrence of Hepatic Complications or Mortality During Follow-Up.

Data are median (IQR) or proportions (% [n]). Hazard ratios in bold are statistically significant (P*Complications include hepatic decompensation, HCC, liver transplantation, or death.†Malignancy includes lymphoma, solid tumors without metastases, and metastatic cancer.